CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,041,676 | -14.3% | 35,359 | -5.1% | 0.02% | -7.7% |
| Q2 2023 | $1,215,486 | -9.4% | 37,262 | -2.2% | 0.03% | -13.3% |
| Q1 2023 | $1,341,021 | -24.8% | 38,108 | -2.1% | 0.03% | -42.3% |
| Q4 2022 | $1,783,406 | -4.4% | 38,922 | +1.1% | 0.05% | -66.5% |
| Q3 2022 | $1,865,000 | +36.7% | 38,498 | +10.9% | 0.16% | +252.3% |
| Q2 2022 | $1,364,000 | +10.2% | 34,708 | +3.2% | 0.04% | +33.3% |
| Q1 2022 | $1,238,000 | -18.8% | 33,637 | +0.6% | 0.03% | -17.5% |
| Q4 2021 | $1,524,000 | +35.7% | 33,441 | +2.9% | 0.04% | +25.0% |
| Q3 2021 | $1,123,000 | – | 32,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |